Files
Download Full Text (1.4 MB)
Contents
- Researchers Explore Possible Applications of Nanotechnology in Cancer Treatment
- Sharing the Burden: Palliative Care Team Helps Patients, Families Through Difficult Times
- UPDATE: Study of Tamoxifen and Raloxifene (STAR) Nearing Completion Recruitment Efforts Focus on Women in Minority, Medically Underserved Populations
- House Call: Getting the Best Treatment
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
2003
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Keywords
Rosenblum, Michael G.; Hazle, John D.; Halas, Naomi; Kroto, H. W.; Curl, Robert F., Jr.; Smalley, R. E. (Richard E.); Nguyen, Thuc; Lockey, Marlene; Braiteh, Fadi; Elsayem, Ahmed; Bruera, Eduardo; Beale, Estela A.; Bevers, Therese; Birkner, Diane Kasek; Shaw-Rice, Judi; Nanomedicine; Nanotechnology; Nanostructures; Fullerenes; Palliative Care; Terminal Care; Bereavement; Tamoxifen; Raloxifene Hydrochloride; Medically Underserved Area; Health Services Accessibility; Breast Neoplasms; Clinical Trial Protocols as Topic; Referral and Consultation; Publications.
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Sutton, Ann; Stuyck, Karen; and Nesom, Gayle, "OncoLog, Volume 48, Number 07/08, July/August 2003" (2003). OncoLog MD Anderson's Report to Physicians (All issues). 121.
https://openworks.mdanderson.org/oncolog/121
Conditions Governing Access
Open
